Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.
PLoS Med. 2020 Oct 1;17(10):e1003363. doi: 10.1371/journal.pmed.1003363. eCollection 2020 Oct.
PLoS Med. 2020.
PMID: 33001984
Free PMC article.
Molecular comparison of interval and screen-detected breast cancers.
Cheasley D, Li N, Rowley SM, Elder K, Mann GB, Loi S, Savas P, Goode DL, Kader T, Zethoven M, Semple T, Fox SB, Pang JM, Byrne D, Devereux L, Nickson C, Procopio P, Lee G, Hughes S, Saunders H, Fujihara KM, Kuykhoven K, Connaughton J, James PA, Gorringe KL, Campbell IG.
Cheasley D, et al. Among authors: kuykhoven k.
J Pathol. 2019 Jun;248(2):243-252. doi: 10.1002/path.5251. Epub 2019 Mar 8.
J Pathol. 2019.
PMID: 30746706
Item in Clipboard
Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
van Geelen CT, Savas P, Teo ZL, Luen SJ, Weng CF, Ko YA, Kuykhoven KS, Caramia F, Salgado R, Francis PA, Dawson SJ, Fox SB, Fellowes A, Loi S.
van Geelen CT, et al. Among authors: kuykhoven ks.
Breast Cancer Res. 2020 Aug 18;22(1):91. doi: 10.1186/s13058-020-01328-0.
Breast Cancer Res. 2020.
PMID: 32811538
Free PMC article.
Item in Clipboard
Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
van Geelen CT, Savas P, Teo ZL, Luen SJ, Weng CF, Ko YA, Kuykhoven KS, Caramia F, Salgado R, Francis PA, Dawson SJ, Fox SB, Fellowes A, Loi S.
van Geelen CT, et al. Among authors: kuykhoven ks.
Breast Cancer Res. 2022 Jul 15;24(1):50. doi: 10.1186/s13058-022-01539-7.
Breast Cancer Res. 2022.
PMID: 35841108
Free PMC article.
No abstract available.
Item in Clipboard
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer.
Teo ZL, O'Connor MJ, Versaci S, Clarke KA, Brown ER, Percy LW, Kuykhoven K, Mintoff CP, Savas P, Virassamy B, Luen SJ, Byrne A, Sant S, Lindeman GJ, Darcy PK, Loi S.
Teo ZL, et al. Among authors: kuykhoven k.
NPJ Breast Cancer. 2023 Aug 15;9(1):68. doi: 10.1038/s41523-023-00568-5.
NPJ Breast Cancer. 2023.
PMID: 37582853
Free PMC article.
Item in Clipboard
Cite
Cite